Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of Stimotimagene Copolymerplasmid in multiple cancer types; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Breast Cancer
• Cervical Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Penile Cancer
• Sarcoma
• Vulvar Cancer

Drugs mentioned

• Stimotimagene Copolymerplasmid

Snippet

Sponsor: Gene Surgery LLC | Conditions: Sarcoma, Melanoma | Phase 1 | Status: COMPLETED